These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 32648233

  • 1. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C, Cheng Z, Jiang T, Xu Y, Wang B.
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q, Hou S, Zhu X, Liu S.
    World J Surg Oncol; 2020 Feb 03; 18(1):29. PubMed ID: 32013999
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M, Chen C, Luo H, Ren J, Dai Q, Hu W, Zhou K, Tang X, Li X.
    Cell Mol Biol Lett; 2020 Nov 03; 25(1):49. PubMed ID: 33292168
    [Abstract] [Full Text] [Related]

  • 4. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P, Lu X, Shi Z, Li X, Zhang Y, Zhao S, Liu H.
    Gene; 2019 Aug 20; 710():103-113. PubMed ID: 31158447
    [Abstract] [Full Text] [Related]

  • 5. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY, Tao YW, Gao S, Li P, Zheng JM, Zhang SE, Liang J, Zhang Y.
    EBioMedicine; 2018 Oct 20; 36():209-220. PubMed ID: 30243489
    [Abstract] [Full Text] [Related]

  • 6. Capn4 regulates Snail to promote the epithelial-mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin-11.
    Yang F, Wang F, Gao ZS, Quang GQ, Hu HB, Zheng M.
    Kaohsiung J Med Sci; 2023 Feb 20; 39(2):134-144. PubMed ID: 36354184
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W, Wang Y, Zhang Q, Luo Q, Huang N, Chen R, Tang X, Li X, Luo H.
    Cell Signal; 2023 Oct 20; 110():110833. PubMed ID: 37543098
    [Abstract] [Full Text] [Related]

  • 8. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y, Wang M, Li X, Cui F.
    Yonsei Med J; 2019 Apr 20; 60(4):336-345. PubMed ID: 30900419
    [Abstract] [Full Text] [Related]

  • 9. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
    Mackiewicz M, Huppi K, Pitt JJ, Dorsey TH, Ambs S, Caplen NJ.
    Breast Cancer Res Treat; 2011 Nov 20; 130(2):663-79. PubMed ID: 21814748
    [Abstract] [Full Text] [Related]

  • 10. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
    Huang P, Li M, Tang Q, Jiang K, Luo Y.
    Apoptosis; 2022 Oct 20; 27(9-10):751-761. PubMed ID: 35759163
    [Abstract] [Full Text] [Related]

  • 11. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
    Jiang C, Zhou L, Wang H, Zhang Q, Xu Y.
    Adv Clin Exp Med; 2016 Oct 20; 25(3):531-7. PubMed ID: 27629742
    [Abstract] [Full Text] [Related]

  • 12. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN, Zhu H, Li LP, Jin AY, Wang HQ.
    Eur Rev Med Pharmacol Sci; 2019 Sep 20; 23(18):7935-7942. PubMed ID: 31599418
    [Abstract] [Full Text] [Related]

  • 13. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 20; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 14. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W.
    Oncol Rep; 2014 Aug 20; 32(2):559-66. PubMed ID: 24889918
    [Abstract] [Full Text] [Related]

  • 15. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L, Chen L, Luan Q, Kong Q.
    J Cell Physiol; 2019 Aug 20; 234(10):17912-17924. PubMed ID: 30834525
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
    Zhang Y, Zhang H, Li X.
    J BUON; 2020 Aug 20; 25(3):1579-1586. PubMed ID: 32862607
    [Abstract] [Full Text] [Related]

  • 17. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, Marincola FM, Yao KT, Fang WY, Cai HB, Li X.
    Oncogene; 2015 Apr 23; 34(17):2156-66. PubMed ID: 25347742
    [Abstract] [Full Text] [Related]

  • 18. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 23; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression.
    Xu J, Li B, Song W, Cao L, Zhu C, Lin S.
    Int J Biochem Cell Biol; 2021 Dec 23; 141():106092. PubMed ID: 34626803
    [Abstract] [Full Text] [Related]

  • 20. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G, Du MY, Zhu H, Zhang N, Lu ZW, Qian LX, Zhang W, Tian X, He X, Yin L.
    Biomed Pharmacother; 2018 Oct 23; 106():217-224. PubMed ID: 29960168
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.